MedPath

Nutrient and Immunity Status in Children Aged 3-5 Years Consuming Their Habitual Diet With or Without Fortified Milk

Not Applicable
Completed
Conditions
Nutritional Status
Child Nutrition Sciences
Toddlers
Interventions
Other: Fortified milk
Registration Number
NCT05440604
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

This study compares the status of key micronutrients (vitamins A, C, D, E, and zinc) in young children given investigational fortified milk versus young children consuming their habitual pattern of beverage intake (milk and non-milk beverages).

Detailed Description

Hypothesis that Vitamin A, C, D, E and zinc status of children consuming 2 servings / day of fortified milk for 16 weeks will be better than those of children consuming their habitual pattern of beverage intake (milk and non-milk beverages, juices, sugar-sweetened drinks) for the same duration. This is based on previous study findings that (i) the toddler's and preschooler's diet, in reality, are often not optimal, putting toddlers and preschool age children at risk of insufficient intakes of several nutrients, and (ii) consuming fortified milk supplemented with these nutrients might provide optimal intakes of these nutrients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
112
Inclusion Criteria
  1. Having obtained his/her parent's(s') or his/her legal guardian written informed consent and signed and dated informed consent.
  2. Child's parent(s)/guardian is/are of legal age of consent, must understand the informed consent and other study documents, and is/are willing and able to fulfill the requirements of the study protocol
  3. Age 3 years old to 4 years old and 6 months at enrolment
  4. Healthy at birth, singleton, full-term gestational birth (37-42 completed weeks of gestation), with a birth weight of 2.5 kg to 3.9 kg
  5. At the time of enrolment, the participant's weight-for-age, height-for-age, weight-for-height, BMI z-score should be within -2 to +1
  6. At the time of enrolment, the participant is in good health (no history of underlying metabolic or chronic disease; congenital malformation; or any other condition which, in the opinion of the investigator, is likely to interfere with: the ability of the child to ingest food, the normal growth and development of the child, or the evaluation of the infant; acute illness in a minor condition which are common in childhood such as viral or bacterial infection e.g. conjunctivitis, otitis media, upper/lower respiratory tract infection, gastroenteritis, hand foot & mouth disease at time of enrolment is permitted) as determined by physical history, physical exam and judgement by the investigator
  7. Child's parent(s)/guardian can be contacted directly by telephone or mobile phone throughout the study
Exclusion Criteria
  1. Chronic infectious, metabolic, genetic illness, or other disease including any condition that impacts feeding, or any outcome measures
  2. Child exhibits any clinical signs of potential micronutrient deficiencies (e.g., hemoglobin < 100 g/L based on screening assessment, rickets based on physical exam).
  3. Known or suspected cows' milk protein intolerance / lactose intolerance /allergy or severe food allergies that impact diet
  4. Breast milk used exclusively / mixed in place of all other milk, and/or milk alternatives at 3 years of age
  5. Consuming supplement(s) of relevance to the study outcome relating diet to status, vitamins A, D, E and C; zinc
  6. Child's family who in the Investigator's judgment cannot be expected to comply with the protocol or study procedures

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fortified milk groupFortified milk2 daily servings of the investigational fortified milk for 16 weeks
Primary Outcome Measures
NameTimeMethod
change in vitamin C status16 weeks

measure in plasma vitamin C in mg/dL

change in vitamin E status16 weeks

measure in plasma alpha-tocopherol in mg/L

change in vitamin A status16 weeks

measure in serum retinol in μmol/L

change in vitamin D status16 weeks

measure in serum 25-hydroxy vitamin D (25\[OH\]D) in nmol/L

change in zinc status16 weeks

measure in plasma zinc in μg/dl

Secondary Outcome Measures
NameTimeMethod
assess dietary intake4 weeks, 8 weeks, 12 weeks, 16 weeks

using a 24-hour Dietary Recall completed by the parent / caregiver

nucleotides status assessment16 weeks

measure concentration of nucleotides

monitor growth and development16 weeks

anthropometry assessment measured by BMI (kg/m\^2)

assess child developmental milestones16 weeks

using Laban Quotient to assess physical, social, self-help and cognitive; minimum score 1 , maximum 5; higher scores indicate more positive outcomes

assess fortified milk acceptability4 weeks, 8 weeks, 12 weeks, 16 weeks

using Milk Intake Diary for interventional group completed by the parent / caregiver

monitor absenteeism from day care or pre-school due to illness16 weeks

safety assessment by monitoring the days of absenteeism linked with participation in study

monitor concomitant medication (CM) reporting16 weeks

safety assessment by monitoring number of participants that took concomitant medication linked with participation in study

assess habitual pattern of food and beverage intake16 weeks

using a semi-quantitative food frequency questionnaire completed by the parent / caregiver

monitor standard adverse events (AE)16 weeks

safety assessment by monitoring the AEs linked with participation in study

Trial Locations

Locations (1)

Las Piñas Doctors Hospital

🇵🇭

Las Piñas, Metro Manila, Philippines

© Copyright 2025. All Rights Reserved by MedPath